The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
MRI has emerged as one of several urgently needed candidate disease progression biomarkers for the neurodegenerative disorder amyotrophic lateral sclerosis (ALS), not least due to its unique ability to non-invasively assess structural and functional cerebral pathology. We sought to identify the exte...
Auteurs principaux: | Menke, R, Proudfoot, M, Talbot, K, Turner, M |
---|---|
Format: | Journal article |
Publié: |
Elsevier
2017
|
Documents similaires
-
The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
par: R.A.L. Menke, et autres
Publié: (2018-01-01) -
Imaging cerebral activity in amyotrophic lateral sclerosis
par: Proudfoot, M, et autres
Publié: (2019) -
Motor system biomarkers in amyotrophic lateral sclerosis
par: Edmond, EC, et autres
Publié: (2019) -
Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.
par: Menke, R, et autres
Publié: (2014) -
Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis
par: Malcolm Proudfoot, et autres
Publié: (2019-01-01)